Is Vazkepa looked at as a valuable drug? We now have ((8)) generics in the US market. Yes there is a big recognition of Vasecpa making a difference in CV care. The Europeans are a little slow in understanding a statin patient being released from the hospital after a heart attack should see Vazkepa added to their therapy. Getting to a critical number of patients and doctors in Europe will put a lot of pressure on other doctors to get on top of what is the best care for these patients. That would be hundred of thousands of HA patients that should at teast be given the choice. . My Doc still thinks fish oil has some medicinal value. This year he finally brought up Vascepa to me as off label use as my blood lipids edged into the treatment zone. I've actually talked to him about Vascepa in the past and he was clueless and always acted uninterested. European medicine is apparently not incentivized to keep up to date and are also on the slow track with Vazkepa. I think once that snowball of Vazkepa users gets big enough there is real potential Vaskepe it will gain traction. My Doc was actually interested in me starting Vascepa off label, for me that was a huge statement.
Market Data 
Markets 
AI
